A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population
- PMID: 12601293
A search for association between hereditary hemochromatosis HFE gene mutations and type 2 diabetes mellitus in a Polish population
Abstract
Background: Hereditary hemochromatosis (HH) is characterized by excess iron deposition. Two mutations in the HFE gene are associated with HH. Heterozygous carriers of HFE mutations are at higher risk of developing type 2 diabetes mellitus (T2DM). The aims of our project were to identify the frequency of C282Y and H63D mutations in a population from the Małopolska region of south-eastern Poland, and to search for an association of HFE mutations with T2DM.
Material/methods: We included 391 individuals in this study: 222 T2DM patients and 169 controls. Genotypes were determined by electrophoresis of the DNA digestion products from SnaBI and DpnII, respectively. Differences in distributions between the groups were then analyzed by the chi-squared test.
Results: The frequency of wild/C282Y alleles was 98.2%/1.8% in T2DM patients and 96.7%/3.2% in controls (p=0.19). The frequency of wild/H63D alleles was 85.6%/14.4% and 88.8%/11.2% (p= 0.19), respectively. The distribution of genotypes was not statistically different. However, in stratified analyses based on age of T2DM onset and gender, we observed a higher prevalence of wild/H63D and H63D/H63D genotypes among T2DM patients diagnosed at > 49 years of age, the mean age for the entire group (p=0.018), and among male T2DM individuals (p=0.005) than in controls.
Conclusions: The frequency of HH-associated mutations in this population from south-eastern Poland is similar to other Caucasians. We found no evidence for the association of the C282Y mutation with T2DM. The results do suggest, however, that the H63D mutation may play a role in the pathogenesis of late onset T2DM and in males in this Polish population.
Similar articles
-
Prevalence of C282Y, H63D, and S65C mutations in hereditary HFE-hemochromatosis gene in Lithuanian population.Ann Hematol. 2012 Apr;91(4):491-5. doi: 10.1007/s00277-011-1338-5. Epub 2011 Sep 27. Ann Hematol. 2012. PMID: 21947086
-
Hemochromatosis gene (HFE) mutations in patients with type 2 diabetes and their control group in an Iranian population.Saudi Med J. 2008 Jun;29(6):808-12. Saudi Med J. 2008. PMID: 18521456
-
Frequency of HFE H63D, S65C, and C282Y mutations in patients with iron overload and controls from Toledo, Spain.Genet Test. 2004 Fall;8(3):263-7. doi: 10.1089/gte.2004.8.263. Genet Test. 2004. PMID: 15727249
-
Mutations of the HFE gene among Turkish hereditary hemochromatosis patients.Ann Hematol. 2005 Oct;84(10):646-9. doi: 10.1007/s00277-005-1048-y. Epub 2005 May 4. Ann Hematol. 2005. PMID: 15871018
-
HFE mutations and Alzheimer's disease.J Alzheimers Dis. 2006 Nov;10(2-3):267-76. doi: 10.3233/jad-2006-102-311. J Alzheimers Dis. 2006. PMID: 17119292 Review.
Cited by
-
The HFE gene is associated to an earlier age of onset and to the presence of diabetic nephropathy in diabetes mellitus type 2.Endocrine. 2004 Jul;24(2):111-4. doi: 10.1385/ENDO:24:2:111. Endocrine. 2004. PMID: 15347835
-
Compound heterozygote (C282Y/H63D) of hereditary hemochromatosis in a 16-year-old girl with hypoplastic kidney.Int J Hematol. 2007 May;85(4):300-3. doi: 10.1532/IJH97.E0605. Int J Hematol. 2007. PMID: 17483072
-
Haemochromatosis gene frequency in a control and diabetic Irish population.Ir J Med Sci. 2009 Mar;178(1):39-42. doi: 10.1007/s11845-008-0248-6. Epub 2008 Nov 11. Ir J Med Sci. 2009. PMID: 19002551
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical